| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00108-017-0347-4 |
| P698 | PubMed publication ID | 29110023 |
| P2093 | author name string | C P Strassburg | |
| P2860 | cites work | Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis | Q56971225 |
| EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis | Q59384401 | ||
| Sertraline as a first-line treatment for cholestatic pruritus | Q61480066 | ||
| Treatment of primary biliary cirrhosis and cholestatic disorders with ursodeoxycholic acid | Q69904854 | ||
| Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial | Q73026352 | ||
| Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid | Q73401694 | ||
| Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome | Q84441124 | ||
| Ursodeoxycholic acid for primary biliary cirrhosis | Q24202184 | ||
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus | Q33280833 | ||
| Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis | Q33745849 | ||
| Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid. | Q34453425 | ||
| An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis | Q34608494 | ||
| Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses | Q36801651 | ||
| Proposed therapies in primary biliary cholangitis | Q37072380 | ||
| Obeticholic acid and budesonide for the treatment of primary biliary cirrhosis | Q38175055 | ||
| Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
| The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial | Q42947273 | ||
| Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study | Q43471968 | ||
| Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic Acid | Q43483632 | ||
| Impact of primary biliary cirrhosis on perceived quality of life: the UK-PBC national study | Q43725734 | ||
| The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort. | Q44293400 | ||
| Primary biliary liver cirrhosis and overlap syndrome. Diagnosis and therapy | Q44736205 | ||
| A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis | Q45040478 | ||
| Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid | Q46126105 | ||
| Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid | Q46489034 | ||
| Investigational drugs in phase II clinical trials for primary biliary cholangitis. | Q53098304 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’ | Q56428277 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | ascending cholangitis | Q603644 |
| P304 | page(s) | 105-112 | |
| P577 | publication date | 2017-11-06 | |
| P1433 | published in | Die Innere Medizin | Q1194574 |
| P1476 | title | Modern treatment of primary biliary cholangitis | |
| P478 | volume | 59 |
Search more.